South Korean deal fuels growth for Memphis biotech biz
Hera Health Solutions CEO Idicula Mathew (left) signs an agreement with Geovista CEO Dr. Gook Jun Ahn in Seoul, South Korea, on Oct. 17. (Courtesy Idicula Mathew)
Hera Health is experiencing a growth spurt after striking a deal that allows a South Korean company to use technology developed in Memphis in Asia’s veterinary-drug market.
Topics
Hera Health Solutions Idicula Mathew pharmaceuticals biotech EpiCenterAisling Mäki
Aisling Mäki covers health care, banking and finance, technology and professions. After launching her career in news two decades ago, she worked in public relations for almost a decade before returning to journalism in 2022.
As a health care reporter, she’s collaborated with The Carter Center, earned awards from the Associated Press and Society of Professional Journalists and won a 2024 Tennessee Press Association first-place prize for her series on discrepancies in Shelby County life expectancy by ZIP code.
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.